Диссертация (1145983), страница 34
Текст из файла (страница 34)
Margaglione, D. Colaizzo [et al.] // Thromb Haemost. - 1997. Vol. 77, № 6. - P. 1052-1054.131. Gunel, T. Serum microRNA expression in pregnancies with preeclampsia / T. Gunel, Y.G.Zeybek, P. Akçakaya [et al.] // Genet. Mol. Res. - 2011. - Vоl. 10, № 4. - P. 4034-4040.139132. Haase, C. L. Mutation in APOA1 predicts increased risk of ischaemic heart disease and totalmortality without low HDL cholesterol levels / C. L.
Haase, R.Frikke-Schmidt, B. G.Nordestgaard [et al.] // The J Intern Med. - 2011. - Vol. 270, № 2. - P. 136 - 146.133.Hall, S. A common mutation in the lipoprotein lipase gene promoter, -93T/G, is associated withlower plasma triglyceride levels and increased promoter activity in vitro / S. Hall, G. Chu, G.Miller [et al.] // Arterioscler Thromb Vasc Biol. - 1997.
- Vol. 17, № 10. - P. 1969–1976.134. Haram, K. Genetic aspects of preeclampsia and the HELLP syndrome / K. Haram, J. H.Mortensen, B. Nagy // Journal of Pregnancy. - 2014. - Vol. 2014, № 2014. Article ID 910751. 13 p.135.Harapan, H. The role of microRNAs in the proliferation, differentiation, invasion, andapoptosis of trophoblasts during the occurrence of preeclampsia—A systematic review / H.Harapan, M. Andalas // Tzu Chi Medical Journal.
- 2015. - Vol. 27, № 2. - P. 54–64.136.Harapan, H. The role of microRNAs on angiogenesis and vascular pressure in preeclampsia:The evidence from systematic review/ H. Harapan, C. M. Yeni // Egyptian Journal of MedicalHuman Genetics. - 2015. - Vol. 16, № 4. - P. 313–325.137.Harrison, G. A. A genomewide linkage study of preeclampsia/eclampsia reveals evidence for acandidate region on 4q / G. A. Harrison, K. E. Humphrey, N. Jones [et al.] // Am J Hum Genet.- 1997.
- Vol. 60, № 5. - P. 1158–1167.138.Hayward, C. An exclusion map for pre-eclampsia: assuming autosomal recessive inheritance /C. Hayward, J. Livingstone, S. Holloway [et al.] // Am J Hum Genet. - 1992. - Vol. 50, № 4. P. 749–757.139.He, P. Analysis of gene expression identifies candidate markers and pathways in pre-eclampsia/ P. He, D. Shao, M. Ye, G. Zhang // J Obstet Gynaecol.
- 2014. - Vol. 22. - P. 1-7.140. Hill, L. D. Fetal ERAP2 variation is associated with preeclampsia in African Americans in acase-control study / L. D. Hill, D. D. Hilliard, T. P. York [et al.] // BMC Med Genet. - 2011 Vol. 12: 64. - 10 p.141. Honda, S. The impact of three-dimensional structure on the expression of PlA alloantigens onhuman integrin beta 3 / S.
Honda, Y. Honda, B. Bauer [et al.] // Blood. - 1995. - Vol. 86, № 1. P. 234–242.142. Hosmer, D. W. Applied logistic regression / D. W. Hosmer, S. Lemeshow // 2nd ed. JohnWiley & Sons, Inc. – 2000. - P. 156-164.143.http://omim.org/144.http://www.ensembl.org/145.http://www.gks.ru/146.http://www.hugenavigator.net/140147.http://www.ncbi.nlm.nh.gov/148.http://www.ncbi.nlm.nih.gov/Blast/149.http://www.ncbi.nlm.nih.gov/nucleotide/SNP150. Hu, Y. Differential expression of microRNAs in the placentae of Chinese patients with severepre-eclampsia / Y. Hu, P. Li, S. Hao [et al.] // Clin Chem Lab Med.
- 2009. - Vol. 47, № 8. - P.923-929.151.Hubel, C. A. Association of preeclampsia with common coding sequence variations in thelipoprotein lipase gene / C. A. Hubel, J. M. Roberts, R. E. Ferrell // Clin Genet. - 1999. - Vol.56, № 4. - P. 289–296.152. Humphries, J. O. Occurrence of hypertensive toxemia of pregnancy in mother-daughter pairs /J. O. Humphries // Bull Johns Hopkins Hosp. - 1960. - Vol. 107. - P. 271-277.153. Ikeda, Y. MicroRNAs associated with mitogen-activated protein kinase in human pancreaticcancer / Y. Ikeda, E. Tanji, N.
Makino [et al.] // Mol Cancer Res. - 2012. - Vol. 10, № 2. - P.259-269.154. Irani, R. A. The functional role of the renin-angiotensin system in pregnancy and preeclampsia/ R. A. Irani, Y. Xia // Placenta. - 2008. - Vol. 29, № 9. - P. 763–771.155. Ishibashi, O. Hydroxysteroid (17-β) dehydrogenase 1 is dysregulated by miR-210 and miR518c that are aberrantly expressed in preeclamptic placentas: a novel marker for predictingpreeclampsia / O. Ishibashi, A. Ohkuchi, M.
M. Ali [et al.] // Hypertension. - 2012. - Vol. 59, №2. - P. 265-273.156. Jadaon, M. M. Epidemiology of activated protein C resistance and factor V Leiden mutation inthe mediterranean region / M. M. Jadaon // Mediterr J Hematol Infect Dis. - 2011. - Vol. 3, № 1:e2011037. - 11 p.157. Jenkins, L. D. Preeclampsia risk and angiotensinogen polymorphisms M235T and AGT -217 inAfrican American and Caucasian women / L. D.
Jenkins, R. W. Powers, M. Cooper [et al.] //Reprod Sci. - 2008. - Vol. 15, № 7. - P. 696-701.158. Jimenez, L. M. Scavenger receptor B-I and luteal function in the mouse / L. M. Jimenez, M.Binelli, K. Bertolin [et al.] // J Lipid Res. - 2010. - Vol. 51, № 8. - P. 2362-2371.159.Jin, J. J. Association of endothelin-1 gene variant with hypertension / J. J. Jin, J. Nakura, Z. Wu[et al.] // Hypertension. - Vol. 41, № 1. - P.
163-167.160. Johnson, M. P. Genome-wide association scan identifies a risk locus for preeclampsia on 2q14,near the inhibin, beta B gene / M. P. Johnson, S. P. Brennecke, C. E. East [et al.] // PLoS One. 2012. Vol. 7, № 3: e33666. - 11 p.161. Johnson, M.
P. Identification of two novel quantitative trait loci for pre-eclampsiasusceptibility on chromosomes 5q and 13q using a variance components-based linkage approach141/ M. P. Johnson, E. Fitzpatrick, T. D. Dyer [et al.] // Mol Hum Reprod. - 2007. - Vol. 13, № 1. P. 61-67.162. Johnson, M. P.
The ERAP2 gene is associated with preeclampsia in Australian and Norwegianpopulations / M. P. Johnson, L. T. Roten, T. D. Dyer [et al.] // Hum Genet. - 2009. - Vol. 126,№ 5. - P. 655-666.163. Juárez-Meavepeña, M. The Srb1+1050T allele is associated with metabolic syndrome inchildren but not with cholesteryl ester plasma concentrations of high-density lipoproteinsubclasses / M. Juárez-Meavepeña, E.
Carreón-Torres, C. López-Osorio [et al.] // Metab SyndrRelat Disord. - 2012. - Vol. 10, № 2. - P. 110-116.164. Jurkovicova, D. Cardiovascular diseases and molecular variants of the rennin-angiotensinsystem components in Slovak population / D. Jurkovicova, B. Sedlakova, I. Riecansky [et al.] //Gen. Physiol. Biophys. - 2007.
- Vol. 26, № 1. - P. 27-32.165. Kahn, S. R. Inherited thrombophilia and preeclampsia within a multicenter cohort: theMontreal Preeclampsia Study / S. R. Kahn, R. Platt, H. McNamara [et al.] // Am J ObstetGynecol. - 2009. - Vol. 200, № 2. - P. 151.e1–151.e9, discussion e1–e5.166. Kanasaki, K. Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol isassociated with pre-eclampsia / K. Kanasaki, K. Palmsten, H. Sugimoto [et al.] // Nature.
2008. - Vol. 453, № 7198. - P. 1117-1121.167. Kanasaki, K. The biology of preeclampsia / K. Kanasaki, R. Kalluri // Kidney Int. - 2009. Vol. 76, № 8. - P. 831-837.168. Kankova, K. Lack of association between pregnancy-induced hypertension and familialthrombophilia in a Czech population / K. Kankova, V. Benes, V.
Unzeitig [et al.] // PrenatNeonatal Med. - 2000. - Vol. 5, № 4. - P. 223-229.169.Kilpatrick, D. C. Association between susceptibility to pre-eclampsia within families and HLADR4 / D. C. Kilpatrick, W. A. Liston, F. Gibson, J. Livingstone // Lancet. - 1989. - Vol. 2, №8671. - P. 1063-1065.170. Kim, Y. J. Lipoprotein lipase gene mutations and the genetic susceptibility of preeclampsia /Y.
J. Kim, R. A. Williamson, K. Chen [et al.] // Hypertension. - 2001. - Vol. 38, № 5. - P. 992996.171. Kim, Y. J. Reduced L-arginine level and decreased placental eNOS activity in preeclampsia /Y. J. Kim, H. S. Park, H. Y. Lee [et al.] // Placenta. - 2006. - Vol. 27, № 4-5. - P. 438-444.172.
Kjellberg, U. Factor V Leiden mutation and pregnancy-related complications / U. Kjellberg,M. van Rooijen, K. Bremme, M. Hellgren // Am. J. Obstet. Gynecol. - 2010. - Vol. 203, № 5. P. 469e1–469e8.142173. Knyrim, E. Genetic analysis of the angiotensinogen gene in pre-eclampsia: study of germanwomen and review of the literature / E.
Knyrim, S. Muetze, T. Eggermann [et al.] // GynecolObstet Invest. - 2008. - Vol. 66, № 3. - P. 203-208.174.Kobashi,G.Absenceofassociationbetweenacommonmutationinthemethylenetetrahydrofolate reductase gene and preeclampsia in Japanese women / G. Kobashi,H. Yamada, T. Asano [et al.] // Am J Med Genet. - 2000. - Vol.
93, № 2. - P. 122-125.175. Kobashi, G. Endothelial nitric oxide synthase gene (NOS3) variant and hypertension inpregnancy / G. Kobashi, H. Yamada, K. Ohta [et al.] // Am J Med Genet. - 2001. - Vol. 103, №3. - P. 241-244.176. Kobashi, G. Genetic and environmental factors associated with the development ofhypertension in pregnancy / G.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
